Apotex Pty Ltd — APO-Cabergoline 500mcg tablets

PRA number

2016/15641

Published date

Product description

APO-Cabergoline is a medicine used to prevent the production of breast milk in women after giving birth, or to treat abnormally high levels of prolactin.
AUST R 218126
Photograph o fthe product APO-Cabergoline 500mcg tablets
Identifying features
Batch Number MK0903.
Expiry date February 2017.

What are the defects?

Apotex Pty Ltd is recalling one batch of the APO-Cabergoline 500mcg tablets (batch MK0903, expiry date February 2017) due to a packaging issue, where the desiccant may not protect the product from moisture throughout its shelf life.

What are the hazards?

Failure to protect the product from moisture could lead to the product degrading over time in moist conditions. Product degradation may affect the efficacy of the product.

What should consumers do?

If you, or someone you provide care for use APO-Cabergoline, please check the batch number displayed on the bottle label or base of the carton.
 
If the product is from batch MK0903, return the product to the pharmacy where it was purchased for a refund or a replacement product.
 
If you have any concerns or queries, speak to your health professional or contact Apotex Medical Information on 1800 195 055.

Supplier

Apotex Pty Ltd

Where the product was sold

Nationally

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category